Stock DNA
Pharmaceuticals & Biotechnology
CNY 8,905 Million (Mid Cap)
30.00
NA
1.34%
-0.60
15.58%
4.72
Revenue and Profits:
Net Sales:
304 Million
(Quarterly Results - Jun 2025)
Net Profit:
99 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.15%
0%
-10.15%
6 Months
2.88%
0%
2.88%
1 Year
-10.74%
0%
-10.74%
2 Years
0.55%
0%
0.55%
3 Years
-19.61%
0%
-19.61%
4 Years
-50.84%
0%
-50.84%
5 Years
-48.36%
0%
-48.36%
Amoy Diagnostics Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.93%
EBIT Growth (5y)
18.61%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.63
Sales to Capital Employed (avg)
0.58
Tax Ratio
11.23%
Dividend Payout Ratio
46.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
33.98%
ROE (avg)
15.98%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
4.72
EV to EBIT
25.58
EV to EBITDA
21.35
EV to Capital Employed
10.23
EV to Sales
6.85
PEG Ratio
3.42
Dividend Yield
1.34%
ROCE (Latest)
39.98%
ROE (Latest)
15.58%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
303.50
308.00
-1.46%
Operating Profit (PBDIT) excl Other Income
118.00
87.90
34.24%
Interest
0.70
0.20
250.00%
Exceptional Items
1.40
2.00
-30.00%
Consolidate Net Profit
98.60
79.70
23.71%
Operating Profit Margin (Excl OI)
337.30%
236.30%
10.10%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -1.46% vs 17.42% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 23.71% vs 14.84% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,103.90
1,038.80
6.27%
Operating Profit (PBDIT) excl Other Income
334.30
327.60
2.05%
Interest
1.70
1.60
6.25%
Exceptional Items
-17.20
-5.00
-244.00%
Consolidate Net Profit
254.90
261.50
-2.52%
Operating Profit Margin (Excl OI)
249.20%
258.40%
-0.92%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 6.27% vs 23.89% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -2.52% vs -1.06% in Dec 2023
About Amoy Diagnostics Co., Ltd. 
Amoy Diagnostics Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






